Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mehta

Showing results (191-200 of 1,154) with videos related to

Pageof 116
Sort By:
Current Opinion in Critical Care|October 12, 2020
Identification of acute kidney injury subphenotypesZoltan H Endre, Ravindra L Mehta
Drugs|November 1, 1990
The potential role of thromboxane inhibitors in preventing myocardial ischaemic injuryJ L Mehta, W W Nichols
Drug Intelligence & Clinical Pharmacy|December 1, 1985
Long-term experience with lofexidine in the treatment of mild-to-moderate essential hypertensionL M Lopez, J L Mehta
Current Opinion in Cardiology|August 12, 2005
C-reactive protein and cardiovascular disease: a critical appraisalJorge L Sepulveda, Jawahar L Mehta
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|September 1, 1975
Letter: Combined heat-irradiation effect on deoxyribonucleic acid of Penicillium expansum LK. ex. ThomM K Roy, S L Mehta
American Journal of Nephrology|July 7, 1999
Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on DialysisR L Mehta, J M Letteri
Cardiovascular Research|October 28, 1999
Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?J L Mehta, D Y Li
Journal of Cardiovascular Pharmacology and Therapeutics|January 11, 2001
Glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes: conquests and new challengesK M Smith, J L Mehta
Cardiovascular Clinics|January 1, 1987
Anticoagulation in coronary heart disease: heparin and warfarin trialsL M Lopez, J L Mehta
Comprehensive Therapy|March 1, 1986
Hypertension in the elderly: pathophysiology and therapeutic implicationsJ L Mehta, L M Lopez
Pageof 116

Showing results (191-200 of 1,154) with videos related to

Sort By:
Pageof 116
Current Opinion in Critical Care|October 12, 2020
Identification of acute kidney injury subphenotypesZoltan H Endre, Ravindra L Mehta
Drugs|November 1, 1990
The potential role of thromboxane inhibitors in preventing myocardial ischaemic injuryJ L Mehta, W W Nichols
Drug Intelligence & Clinical Pharmacy|December 1, 1985
Long-term experience with lofexidine in the treatment of mild-to-moderate essential hypertensionL M Lopez, J L Mehta
Current Opinion in Cardiology|August 12, 2005
C-reactive protein and cardiovascular disease: a critical appraisalJorge L Sepulveda, Jawahar L Mehta
International Journal of Radiation Biology and Related Studies in Physics, Chemistry, and Medicine|September 1, 1975
Letter: Combined heat-irradiation effect on deoxyribonucleic acid of Penicillium expansum LK. ex. ThomM K Roy, S L Mehta
American Journal of Nephrology|July 7, 1999
Current status of renal replacement therapy for acute renal failure. A survey of US nephrologists. The National Kidney Foundation Council on DialysisR L Mehta, J M Letteri
Cardiovascular Research|October 28, 1999
Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?J L Mehta, D Y Li
Journal of Cardiovascular Pharmacology and Therapeutics|January 11, 2001
Glycoprotein IIb/IIIa receptor inhibitors in acute coronary syndromes: conquests and new challengesK M Smith, J L Mehta
Cardiovascular Clinics|January 1, 1987
Anticoagulation in coronary heart disease: heparin and warfarin trialsL M Lopez, J L Mehta
Comprehensive Therapy|March 1, 1986
Hypertension in the elderly: pathophysiology and therapeutic implicationsJ L Mehta, L M Lopez
Pageof 116